Can Anti-Inflammatory eye drops slow diabetic retinopathy?
NCT ID NCT04505566
First seen Nov 01, 2025 · Last updated May 24, 2026 · Updated 34 times
Summary
This study looks at how inflammation affects diabetic retinopathy, an eye disease that can lead to vision loss in people with diabetes. Researchers are measuring inflammatory markers in eye fluid and testing whether ketorolac eye drops can reduce these markers and slow disease progression. About 164 adults with type 2 diabetes are participating over one year.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for DIABETIC RETINOPATHY are added.
Genom att skicka in godkänner du våra Användarvillkor
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
Genom att skicka in godkänner du våra Användarvillkor
Locations
-
Vanderbilt University Medical Center
Nashville, Tennessee, 37232, United States
Conditions
Explore the condition pages connected to this study.